1X10^6 human PBMCs were surface co-stained with FITC anti-Human CD3 and 0.2 ug Anti-Human CD2 (65192-1-Ig, Clone:TS1/8) labeled with FlexAble CoraLite® Plus 647 Antibody Labeling Kit for Mouse IgG1 (KFA023) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD2 (65192-1-Ig, Clone:TS1/8) labeled with FlexAble CoraLite® Plus 647 Antibody Labeling Kit for Mouse IgG1 (KFA023) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul Atlantic Blue™ Anti-Human CD2 (AB-65192, Clone:TS1/8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD2 (AB-65192, Clone:TS1/8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CL647 Anti-Human CD3 and 5 ul Cardinal Red™ Anti-Human CD2 (CR-65192, Clone:TS1/8) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Cardinal Red™ Anti-Human CD2 (CR-65192, Clone:TS1/8) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CL647 Anti-Human CD3 and 5 ul CoraLite® Plus 405 Anti-Human CD2 (CL405-65192, Clone:TS1/8) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 405 Anti-Human CD2 (CL405-65192, Clone:TS1/8) (red) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CoraLite® Plus 647 Anti-Human CD3 and 5 ul CoraLite® Plus 488 Anti-Human CD2 (CL488-65192, Clone:TS1/8), or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD2 (CL488-65192, Clone:TS1/8) (red), or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD3 and 5 ul CoraLite® Plus 555 Anti-Human CD2 (CL555-65192, Clone:TS1/8) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human CD2 (CL555-65192, Clone:TS1/8) (red) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul CoraLite® Plus 647 Anti-Human CD2 (CL647-65192, Clone:TS1/8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 647 Anti-Human CD2 (CL647-65192, Clone:TS1/8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul CoraLite®750 Anti-Human CD2 (CL750-65192, Clone:TS1/8 or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®750 Anti-Human CD2 (CL750-65192, Clone:TS1/8 or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---